I don't think dividend cuts are off the table either, but as long as they aren't extreme it will remain attractive. Hindsight is 20/20, but I am wishing they would have diversified away from industries that both political parties and the FDA have no problem bashing. Same could be said for Pharma though.
For now it is what it is. MO is a yield trap as anyone who has held it long lost half their capital. I'm in pretty deep now so I can complain here if I want. I guess the $52.50 covered calls I sold are going to expire worthless tomorrow?
For now it is what it is. MO is a yield trap as anyone who has held it long lost half their capital. I'm in pretty deep now so I can complain here if I want. I guess the $52.50 covered calls I sold are going to expire worthless tomorrow?